Delivery Order SPE2DB20D3505-SPE2DB25FT9L9

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.56 firm fixed-price delivery order covers the supply of Ramelteon 8 mg tablets for the DLA Troop Support Medical program. The contract has a period of performance through November 27, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $1,430.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramelteon 8 mg tablets, a sleep medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $3,508.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567074312 - RAMELTEON 8 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 29, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,275.26 firm fixed-price delivery order is for the supply of the medication RAMELTEON 8 MG TABLET UD 50S. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $7,695.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.83 Firm Fixed Price Delivery Order is for the supply of 4561454598 - RAMELTEON 8 MG TABLET 30S. The contract has an ultimate completion date of July 11, 2023 and was awarded on July 10, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
This federal contract award, SPE2DB20D1100|SPE2DB25FZ68D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $1,061.28 and a completion date of December 20, 2024. This is a delivery order contract, and no set-aside designation was used. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The Defense Logistics Agency awarded a $246,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30,000 units of 8mg Ramelteon tablets. As a major pharmaceutical distributor, Amerisourcebergen will deliver the insomnia medication to a Defense Department facility located in Conshohocken, Pennsylvania by the scheduled completion date of June 27, 2023. No set aside provisions or subcontracting requirements were specified. The order was placed under an existing...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT9L9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.24 firm fixed-price delivery order is for the supply of Ramelteon 8 MG Tablet UD 50S, a medication used to treat insomnia.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains.

The contract award has no set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the ordered medical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/6/25, 9:44 AM